CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,718 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01499511
NCT01499511N/ACompleted

Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up Study

Imperial College London·observational·Posted Dec 26, 2011·Updated Dec 3, 2019

In Brief

An observational study for Hypertension and 4 related conditions. Completed, enrolled 1,718 participants across 1 site.

Detailed Summary

ASCOT-10 is a follow-up study of surviving participants in the United Kingdom (UK)arm of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) which was conducted between 2000 and 2005.ASCOT's results showed substantial cardiovascular benefit from: 1) the use of a cholesterol lowering drug (atorvastatin) compared to placebo, and 2) the use of a blood-pressure lowering strategy based on amlodipine when compared to a strategy based on atenolol. ASCOT-10 will test the hypothesis that the ASCOT subjects who originally received Atorvastatin and those who received amlodipine based treatment will continue to show a cardiovascular benefit relative to those who did not, even though all the subjects have had access to optimal treatment in the interim.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
CollaboratorsPfizer

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedDec 26, 2011
Enrollment StartJan 1, 2012
Primary CompletionMay 30, 2015
Study CompletionJan 31, 2016
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 14.5 years ago